Many pertinent studies utilize primary cells from PCOS patients; however, this approach is characterized by variability and inadequate reproducibility, and the lack of hormonal intervention may result in the loss of PCOS-associated hormone receptor phenotypes, consequently constraining the validity of the research [58–60]. Here, NR4A1 is linked to polycystic ovary syndrome.